Compare · AIFF vs SNOW
AIFF vs SNOW
Side-by-side comparison of Firefly Neuroscience Inc. (AIFF) and Snowflake Inc. (SNOW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIFF and SNOW operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SNOW is the larger of the two at $109.88B, about 6799.0x AIFF ($16.2M).
- SNOW has been more active in the news (12 items in the past 4 weeks vs 2 for AIFF).
- SNOW has more recent analyst coverage (25 ratings vs 0 for AIFF).
- Company
- Firefly Neuroscience Inc.
- Snowflake Inc.
- Price
- $1.01-3.35%
- $317.01-1.79%
- Market cap
- $16.2M
- $109.88B
- 1M return
- -
- +16.22%
- 1Y return
- -
- +63.12%
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 2
- 12
- Recent ratings
- 0
- 25
Snowflake Inc.
Snowflake Inc. provides cloud-based data platform in the United States and internationally. The company's platform offers Data Cloud, an ecosystem that enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of various sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is headquartered in San Mateo, California.
Latest AIFF
- Firefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
- Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
- SEC Form DEF 14A filed by Firefly Neuroscience Inc.
- SEC Form 424B3 filed by Firefly Neuroscience Inc.
- SEC Form EFFECT filed by Firefly Neuroscience Inc.
- SEC Form PRE 14A filed by Firefly Neuroscience Inc.
- Firefly Neuroscience Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- Amendment: SEC Form S-3/A filed by Firefly Neuroscience Inc.
- Firefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest SNOW
- Director Slootman Frank exercised 300,000 shares at a strike of $8.88 and sold $97,425,065 worth of shares (300,000 units at $324.75) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- Snowflake Unlocks Better AI Economics with Dynamic Model Routing, Delivering More Value to Customers
- Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update
- Director Dageville Benoit sold $16,785,000 worth of shares (50,000 units at $335.70) as part of a pre-agreed trading plan and gifted 16,668 shares (SEC Form 4)
- EVP, Product Management Kleinerman Christian sold $9,750,000 worth of shares (30,000 units at $325.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 340,379 units (SEC Form 4)
- Director Speiser Michael L sold $16,443,128 worth of shares (50,741 units at $324.06) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 22,573 units (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- EVP, Product Management Kleinerman Christian sold $2,969,950 worth of shares (10,000 units at $297.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 365,379 units (SEC Form 4)
- EVP, Product Management Kleinerman Christian sold $8,995,800 worth of shares (29,986 units at $300.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 375,379 units (SEC Form 4)